Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphomaTheodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Maria K. Angelopoulou et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 24
P-43 Effect of the treatment withCA2 anti-TNF monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study groupHelen Α. Papadaki, George D. Eliopoulos, Charalampos Pontikoglou et al.|Leukemia Research|2005Cited by 0